Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
177 0 |
SM ISO690:2012 RAJABI, Mehdi, SIGNORELLI, Paola, GORINCIOI, Elena, GHIDONI, Riccardo, SANTANIELLO, Enzo. Antiproliferative activity of N6-isopentenyladenosine on MCF-7 breast cancer cells: Cell cycle analysis and DNA-binding study. In: DNA and Cell Biology, 2010, vol. 29, nr. 11, pp. 687-691. ISSN 1044-5498. DOI: https://doi.org/10.1089/dna.2010.1073 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
DNA and Cell Biology | ||||||
Volumul 29, Numărul 11 / 2010 / ISSN 1044-5498 | ||||||
|
||||||
DOI:https://doi.org/10.1089/dna.2010.1073 | ||||||
Pag. 687-691 | ||||||
|
||||||
Rezumat | ||||||
N6-Isopentenyladenosine (iPA) is a member of the cytokinins, a family of plant hormones that regulate plant cell growth and differentiation. iPA is present in mammalian cells in a free form, as a mononucleotide in the cytoplasm, or in a tRNA-bound form. Its antiproliferative activity against cancer cells lines has been reported by several authors. We show that iPA inhibits the growth of human breast cancer MCF-7 cells in a dose-dependent manner with a concentration of 12.2μM, which causes 50% inhibition of cell viability. The cell cycle analysis by flow cytometry showed that iPA-induced growth arrest could be associated to apoptosis. The interaction of DNA with iPA was studied in aqueous solution at physiological conditions by ultraviolet-vis spectroscopy. A binding constant KiPA-DNA=4.4×103 M-1 was calculated and this value, together with the shift of absorbance, suggests iPA-DNA interaction at DNA surface. |
||||||
Cuvinte-cheie absorption, apoptosis, Breast Neoplasms, Cell Cycle, Cell Line, tumor, cell proliferation, DNA, Humans, Isopentenyladenosine, Spectrum analysis, Stereoisomerism |
||||||
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-180807</cfResPublId> <cfResPublDate>2010-11-01</cfResPublDate> <cfIssue>11</cfIssue> <cfStartPage>687</cfStartPage> <cfISSN>1044-5498</cfISSN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/180807</cfURI> <cfTitle cfLangCode='EN' cfTrans='o'>Antiproliferative activity of N6-isopentenyladenosine on MCF-7 breast cancer cells: Cell cycle analysis and DNA-binding study</cfTitle> <cfKeyw cfLangCode='EN' cfTrans='o'>absorption; apoptosis; Breast Neoplasms; Cell Cycle; Cell Line; tumor; cell proliferation; DNA; Humans; Isopentenyladenosine; Spectrum analysis; Stereoisomerism</cfKeyw> <cfAbstr cfLangCode='EN' cfTrans='o'><p>N<sup>6</sup>-Isopentenyladenosine (iPA) is a member of the cytokinins, a family of plant hormones that regulate plant cell growth and differentiation. iPA is present in mammalian cells in a free form, as a mononucleotide in the cytoplasm, or in a tRNA-bound form. Its antiproliferative activity against cancer cells lines has been reported by several authors. We show that iPA inhibits the growth of human breast cancer MCF-7 cells in a dose-dependent manner with a concentration of 12.2μM, which causes 50% inhibition of cell viability. The cell cycle analysis by flow cytometry showed that iPA-induced growth arrest could be associated to apoptosis. The interaction of DNA with iPA was studied in aqueous solution at physiological conditions by ultraviolet-vis spectroscopy. A binding constant K<sub>iPA-DNA</sub>=4.4×10<sup>3</sup> M<sup>-1</sup> was calculated and this value, together with the shift of absorbance, suggests iPA-DNA interaction at DNA surface.</p></cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2010-11-01T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2010-11-01T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-27488</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2010-11-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-27492</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2010-11-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-12127</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2010-11-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-27494</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2010-11-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-27490</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2010-11-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfFedId> <cfFedIdId>ibn-doi-180807</cfFedIdId> <cfFedId>10.1089/dna.2010.1073</cfFedId> <cfStartDate>2010-11-01T24:00:00</cfStartDate> <cfFedId_Class> <cfClassId>31d222b4-11e0-434b-b5ae-088119c51189</cfClassId> <cfClassSchemeId>bccb3266-689d-4740-a039-c96594b4d916</cfClassSchemeId> </cfFedId_Class> <cfFedId_Srv> <cfSrvId>5123451</cfSrvId> <cfClassId>eda2b2e2-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>5a270628-f593-4ff4-a44a-95660c76e182</cfClassSchemeId> </cfFedId_Srv> </cfFedId> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-27488</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-27488-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2010-11-01T24:00:00</cfStartDate> <cfFamilyNames>Rajabi</cfFamilyNames> <cfFirstNames>Mehdi</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-27492</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-27492-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2010-11-01T24:00:00</cfStartDate> <cfFamilyNames>Signorelli</cfFamilyNames> <cfFirstNames>Paola</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-12127</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-12127-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2010-11-01T24:00:00</cfStartDate> <cfFamilyNames>Горинчой</cfFamilyNames> <cfFirstNames>Елена</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-27494</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-27494-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2010-11-01T24:00:00</cfStartDate> <cfFamilyNames>Ghidoni</cfFamilyNames> <cfFirstNames>Riccardo</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-27490</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-27490-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2010-11-01T24:00:00</cfStartDate> <cfFamilyNames>Santaniello</cfFamilyNames> <cfFirstNames>Enzo</cfFirstNames> </cfPersName_Pers> </cfPers> <cfSrv> <cfSrvId>5123451</cfSrvId> <cfName cfLangCode='en' cfTrans='o'>CrossRef DOI prefix service</cfName> <cfDescr cfLangCode='en' cfTrans='o'>The service of issuing DOI prefixes to publishers</cfDescr> <cfKeyw cfLangCode='en' cfTrans='o'>persistent identifier; Digital Object Identifier</cfKeyw> </cfSrv> </CERIF>